GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Cyclically Adjusted PS Ratio

Addex Therapeutics (XSWX:ADXN) Cyclically Adjusted PS Ratio : 0.86 (As of Jun. 05, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Addex Therapeutics's current share price is CHF0.0686. Addex Therapeutics's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was CHF0.08. Addex Therapeutics's Cyclically Adjusted PS Ratio for today is 0.86.

The historical rank and industry rank for Addex Therapeutics's Cyclically Adjusted PS Ratio or its related term are showing as below:

XSWX:ADXN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.5   Med: 0.86   Max: 2.38
Current: 0.87

During the past years, Addex Therapeutics's highest Cyclically Adjusted PS Ratio was 2.38. The lowest was 0.50. And the median was 0.86.

XSWX:ADXN's Cyclically Adjusted PS Ratio is ranked better than
87.1% of 504 companies
in the Biotechnology industry
Industry Median: 5.505 vs XSWX:ADXN: 0.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Addex Therapeutics's adjusted revenue per share data for the three months ended in Dec. 2023 was CHF0.002. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is CHF0.08 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Addex Therapeutics Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Addex Therapeutics's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Cyclically Adjusted PS Ratio Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.58

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.22 0.79 0.58

Competitive Comparison of Addex Therapeutics's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Addex Therapeutics's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Cyclically Adjusted PS Ratio falls into.



Addex Therapeutics Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Addex Therapeutics's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0686/0.08
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Addex Therapeutics's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Addex Therapeutics's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.002/106.4612*106.4612
=0.002

Current CPI (Dec. 2023) = 106.4612.

Addex Therapeutics Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200906 0.000 101.608 0.000
200912 0.000 101.610 0.000
201006 0.000 102.102 0.000
201012 0.000 102.138 0.000
201106 0.000 102.678 0.000
201112 0.000 101.408 0.000
201206 0.000 101.596 0.000
201212 0.000 100.968 0.000
201306 0.000 101.466 0.000
201312 0.000 101.036 0.000
201406 0.000 101.517 0.000
201412 0.000 100.704 0.000
201506 0.000 100.464 0.000
201512 0.000 99.386 0.000
201606 0.000 100.088 0.000
201612 0.000 99.380 0.000
201706 0.000 100.285 0.000
201712 0.000 100.213 0.000
201806 0.000 101.435 0.000
201812 0.000 100.906 0.000
201903 0.027 101.571 0.028
201906 0.020 102.044 0.021
201909 0.019 101.396 0.020
201912 0.039 101.063 0.041
202003 0.034 101.048 0.036
202006 0.032 100.743 0.034
202009 0.001 100.585 0.001
202012 0.068 100.241 0.072
202103 0.025 100.800 0.026
202106 0.029 101.352 0.030
202109 0.020 101.533 0.021
202112 0.011 101.776 0.012
202203 0.006 103.205 0.006
202206 0.005 104.783 0.005
202209 0.009 104.835 0.009
202212 0.010 104.666 0.010
202303 0.008 106.245 0.008
202306 0.009 106.576 0.009
202309 0.004 106.570 0.004
202312 0.002 106.461 0.002

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Addex Therapeutics  (XSWX:ADXN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Addex Therapeutics Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (XSWX:ADXN) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021